美医疗欺诈执法行动起诉455人涉65亿美元
SOURCE / Justice.gov-News · National Health Care Fraud Enforcement Action Results in 455 Defendants Charged and Over $6.5 Billion in Intended Fraud Loss Charged
原文
National Health Care Fraud Enforcement Action Results in 455 Defendants Charged and Over $6.5 Billion in Intended Fraud Loss Charged
完整原文
function triggerInterstitialChallenge() {var xhr = new XMLHttpRequest(); xhr.withCredentials = true; xhr.addEventListener("loadend", function() { try { var data = JSON.parse(xhr.responseText); if (data.hasOwnProperty('reload')) { if (data["reload"] == true) { window.location.replace(window.location.href.replace(/[&?]bm-verify=[^#]*/, "")); if(window.location.hash){ window.location.reload(); } } } else if (data.hasOwnProperty('location')) { window.location.replace(data["location"]); } else { window.location.reload(); } } catch (e) { window.location.reload(); }}); xhr.open("POST", "/_sec/verify?provider=interstitial", false); xhr.setRequestHeader("Content-Type", "application/json"); xhr.send(JSON.stringify({"bm-verify": "AAQAAAAN/////5veziq2OnUUyH8OseOK3H6mEkFHaBcDvYMseUziGEcWczY0yAFpoKYh2wBXm0TXR1hdXXS+RgjPGHpkaiLlarD4g+FGv2RSEVZQOQBQihWhcUstlxsw1dLXocSluvVwjKDQeaLfQhbQQqQRI+Wmm/udEGNrBPK34GgotvqQhqXRsc8YEvgCNdDdd+pQwAb9YxL3c51BBEawT7I904NIYCqMbhstgiWMkXX9fsV8dDM4GWPOk4/ijZ4bN49qk2I6lbZGjT5AgdBp9upJUVjUQh+8W0y2QmkzxLTGfbsdrw0aQDguf7gIXB0nUzRRNxGqn+q4f1UIrzeBSJI9B/pCFAG3SMykyyevedvkzfjrjaxLeZOF4uF6pvQj1TmYiw6mNdTnByLUdQ==", "pow": j}));} try {if (document.getElementById("akam-logo")) {document.getElementById("akam-logo").onload = function () {requestAnimationFrame(triggerInterstitialChallenge);}; document.getElementById("akam-logo").onerror = triggerInterstitialChallenge;} else {triggerInterstitialChallenge()}} catch(e) {triggerInterstitialChallenge();}
归纳
美国司法部宣布全国医疗保健欺诈执法行动结果，共起诉455名被告，指控其意图欺诈损失超过65亿美元。该行动涉及多个联邦机构联合调查，针对虚假医疗账单、回扣及处方药滥用等行为。案件涵盖医生、护士、药房及医疗设备公司等主体，部分被告已被定罪或认罪。此次行动是近年来规模最大的医疗欺诈打击之一。
点评
美国此次大规模医疗欺诈执法行动凸显了医疗行业虚假账单与回扣行为的严惩趋势，对跨国医疗企业构成显著合规风险。
法律视角点评
AI 生成 · 人工审核核心关切
美国此次大规模医疗欺诈执法行动凸显了医疗行业虚假账单与回扣行为的严惩趋势，对跨国医疗企业构成显著合规风险。
实务启示
中国法律人需警惕跨境医疗业务中反商业贿赂合规的衔接，尤其是美国《反海外腐败法》与国内《反不正当竞争法》的协同适用。